The accelerating global burden of age-related diseases demands evidence-based interventions that address fundamental aging mechanisms rather than isolated symptoms. This comprehensive analysis positions ginsenosides—the bioactive compounds responsible for ginseng's medicinal properties—as promising multi-target therapeutics capable of simultaneously addressing cellular senescence, mitochondrial dysfunction, and microbiome disruption. Using network pharmacology and molecular docking approaches, researchers mapped how specific ginsenosides interact with aging pathways at the cellular level. The compounds demonstrate particular efficacy in preserving mitochondrial function, the cellular powerhouses whose decline drives many hallmarks of aging, while also modulating oxidative stress responses and maintaining intestinal flora balance critical for healthy aging. However, traditional ginseng consumption delivers relatively low concentrations of these active compounds due to poor bioavailability and variable plant content. The review identifies industrial biosynthesis as a solution, enabling consistent production of specific ginsenoside profiles optimized for anti-aging effects. Advanced delivery systems, including AI-designed targeted formulations and structural modifications, could dramatically enhance absorption and tissue distribution. This represents a significant evolution from traditional herbal medicine toward precision nutrition approaches. While promising, most evidence comes from cellular and animal studies, with human clinical trials still limited. The safety profile appears favorable based on ginseng's long medicinal history, but standardized dosing protocols for anti-aging applications require further validation. This work suggests ginsenosides could become cornerstone ingredients in evidence-based functional foods targeting healthy aging, provided manufacturing and delivery challenges are adequately addressed.